电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

HLA-ABC 抗体

This anti-HLA-ABC antibody is a 小鼠 单克隆 antibody detecting HLA-ABC in FACS. Suitable for 人, Baboon, Cynomolgus 和 猕猴.
产品编号 ABIN5067844
发货至: 中国

Quick Overview for HLA-ABC 抗体 (ABIN5067844)

抗原

See all HLA-ABC 抗体
HLA-ABC

适用

  • 69
  • 28
  • 18
  • 16
  • 14
  • 13
  • 13
  • 12
  • 12
  • 11
  • 7
  • 7
  • 6
  • 6
  • 2
  • 1
人, Baboon, Cynomolgus, 猕猴

宿主

  • 55
  • 10
  • 4
小鼠

克隆类型

  • 59
  • 9
单克隆

标记

  • 28
  • 8
  • 7
  • 5
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This HLA-ABC antibody is un-conjugated

应用范围

  • 52
  • 18
  • 17
  • 14
  • 10
  • 10
  • 9
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

质量等级

GMP Grade

克隆位点

W6-32
  • 原理

    Anti-HLA-ABC Unconjugated Antibody

    产品特性

    Clone W6/32 recognizes a cell surface 45 kD non-polymorphic epitope protein shared among products of the HLA-A, B, and C loci. HLA class I antigen associated with beta 2-microglobulin are expressed by all human nucleated cells and HLA-Class I down regulation occurs frequently in many cancers which might adversely affect the clinical course of cancer and the outcome of T-cell-based immunotherapy. HLA-Class I present specific foreign antigen to CD8+ T cells which play central role against infection, tumor and also generation of autoimmune diseases.

    纯化方法

    Purified

    纯度

    >95 %

    免疫原

    Human Leukocytes

    亚型

    IgG2a, kappa
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    4 °C
  • 抗原

    HLA-ABC

    别名

    HLA-ABC

    途径

    TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!